| Marina Reis Marinho Nogueira, DPT | |
|
375 Wampanoag Trl Ste 403, Riverside, RI 02915-2237 | |
| (401) 270-8770 | |
| (401) 270-8772 |
| Full Name | Marina Reis Marinho Nogueira |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 375 Wampanoag Trl Ste 403, Riverside, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265031264 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT03295 (Rhode Island) | Primary |
| Provider Name | Silver Fern Practice Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1851472914 PECOS PAC ID: 1658266515 Enrollment ID: O20120813000580 |
News Archive
Fuisz Pharma today announced the issuance of U.S. Patent 7,824,612 Bodily fluid analyzer, and system including same and method for programming same.
Nova Southeastern University's College of Pharmacy recently launched America's first Center for Consumer Health Informatics Research to deliver health care solutions through social media and cell phones.
GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion, recommending marketing authorisation for Trobalt™ (retigabine) as an adjunctive treatment of partial onset seizures, with or without secondary generalisation in adults aged 18 years and above with epilepsy.
In a Psycho-Oncology study of 28 women who were being treated for breast cancer and were participating in focus groups, White participants noted that having other breast cancer survivors in their support network was essential for meeting their social support needs.
› Verified 4 days ago
| Provider Name | Pelvic Health & Wellness Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1194319475 PECOS PAC ID: 9133523624 Enrollment ID: O20210805001040 |
News Archive
Fuisz Pharma today announced the issuance of U.S. Patent 7,824,612 Bodily fluid analyzer, and system including same and method for programming same.
Nova Southeastern University's College of Pharmacy recently launched America's first Center for Consumer Health Informatics Research to deliver health care solutions through social media and cell phones.
GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion, recommending marketing authorisation for Trobalt™ (retigabine) as an adjunctive treatment of partial onset seizures, with or without secondary generalisation in adults aged 18 years and above with epilepsy.
In a Psycho-Oncology study of 28 women who were being treated for breast cancer and were participating in focus groups, White participants noted that having other breast cancer survivors in their support network was essential for meeting their social support needs.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marina Reis Marinho Nogueira, DPT 4 Richmond Sq Ste 200, Providence, RI 02906-5117 Ph: (401) 433-4172 | Marina Reis Marinho Nogueira, DPT 375 Wampanoag Trl Ste 403, Riverside, RI 02915-2237 Ph: (401) 270-8770 |
News Archive
Fuisz Pharma today announced the issuance of U.S. Patent 7,824,612 Bodily fluid analyzer, and system including same and method for programming same.
Nova Southeastern University's College of Pharmacy recently launched America's first Center for Consumer Health Informatics Research to deliver health care solutions through social media and cell phones.
GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion, recommending marketing authorisation for Trobalt™ (retigabine) as an adjunctive treatment of partial onset seizures, with or without secondary generalisation in adults aged 18 years and above with epilepsy.
In a Psycho-Oncology study of 28 women who were being treated for breast cancer and were participating in focus groups, White participants noted that having other breast cancer survivors in their support network was essential for meeting their social support needs.
› Verified 4 days ago
Camden Marcotte, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl Ste 403, Riverside, RI 02915 Phone: 401-270-8770 | |
Daniel Florendo, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 375 Wampanoag Trl Ste 403, Riverside, RI 02915 Phone: 401-270-8770 Fax: 401-270-8772 | |
Daria Comeau, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 375 Wampanoag Trl Ste 403, Riverside, RI 02915 Phone: 401-726-7100 Fax: 401-270-8772 | |
Sarah Elizabeth English, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl Ste 403, Riverside, RI 02915 Phone: 401-433-4172 Fax: 401-433-0612 | |
Danielle Parent, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl Ste 403, Riverside, RI 02915 Phone: 401-726-7100 Fax: 401-433-0612 | |
Lindsey Arcand, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Riverside, RI 02915 Phone: 401-433-4172 Fax: 401-433-0612 | |
Kayla Whiting Barrett, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1235 Wampanoag Trl Ste 5, Riverside, RI 02915 Phone: 401-433-4049 Fax: 401-270-0118 |